Submissions now open for Federal Government's Clinical Trials Action Group. [ + ]

Senate inquiry on gene patents now to report in March 2010. [ + ]

The Clinical Trials Action Group is seeking public input into ways it can assist in enhancing Australia as a preferred destination for clinical trials.

The study of patenting and licensing trends in climate change reveal global inequities which could be addressed through improved policymaking.

Thermo Fisher Scientific product lines, including Nalgene, Nunc, Shandon, Finnpippette, Molecular Bio Products (MBP), Matrix, Revco, Heraeus, Sorvall, ABgene, Pierce and Hyclone, as well as the Fisher Chemicals, Maybridge and Acros Organics, will now be available for direct purchase in Australia and New Zealand.

Prima BioMed, QRxPHarma, Sirtex Medical, Primary Health Care, ResMed, Cochlear [ + ]

Australian scientists develop rapid and easy assay that could lead to a new cancer tests and targeted chemotherapy drugs. [ + ]

Lung function test recommended for approval for us in the U.S. by FDA Pulmonary-Allergy Drugs Advisory Committee. [ + ]

Researchers unravel the evolutionary history of box jellyfish, gaining insight in to new antivenoms and treatments. [ + ]

Novartis Australia has received Therapeutic Goods Administration approval for Afinitor. [ + ]

Prima BioMed collaborating with Ian Frazer to develop new oral vaccine for human papillomavirus. [ + ]

Will I stay drier by walking or running in the rain? This handy ap will even calculate what speed you should travel to stay as dry as possible.

Prima Biomed, Living Cell Technologies, Mesoblast, Sirtex, Ramsay Health Care [ + ]

Prima Biomed shares halted pending announcement of oral vaccine for cervical cancer. [ + ]

Early-stage biotechnology companies were hardest hit by the GFC, but NemGenix has made it through by embracing every form of funding available. [ + ]